posted on 2022-04-01, 13:06authored byMichael P. Bancks, Meng-Yun Lin, Alain Bertoni, Wendell M. Futrell, Zhixiu Liu, Brian Ostasiewski, Brian J. Wells, Amresh Hanchate
In this study, researchers reviewed electronic health record data
to assess whether the coronavirus disease 2019 pandemic was associated with
disruptions in diabetes care processes of A1C testing, retinal screening, and
nephropathy evaluation among patients receiving care with Wake Forest Baptist
Health in North Carolina. Compared to the pre-pandemic period, they found an
increase of 13–21 percentage points in the proportion of patients delaying
diabetes care for each measure during the pandemic. Alarmingly, delays in A1C
testing were greatest for individuals with the most severe disease and may
portend an increase in diabetes complications.